Pandora Bio, Inc. — Form D/A
Pandora Bio, Inc. of SUNNYVALE, CA, a company, filed a Form D amendment with the SEC on 2025-01-02. The offering totals $1.0M, of which $410K was reported sold. Industry: Other Technology.
Offering
- Filed: 2025-01-02
- Form: D/A
- Accession: 0001952211-25-000001
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $1.0M
- Amount sold: $410K
- Remaining: $590K
- Minimum investment: $10K
- Investors: 18
- Date of first sale: 2023-05-17
- Revenue range: Decline to Disclose
- SEC file number: 021-481979
Issuer
- Name: Pandora Bio, Inc.
- CIK: 0001952211
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 1669 HOLLENBECK AVE #199, SUNNYVALE, CA, 94087
- Phone: 408-828-2997
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Jason Carlson | Director | Sunnyvale, CA |
| Tara Maddala | Director | Sunnyvale, CA |
| Megan Rothney | Director | Sunnyvale, CA |
| Tara Maddala | Executive Officer | Sunnyvale, CA |
| Megan Rothney | Executive Officer | Sunnyvale, CA |
Other filings by this issuer (1)
More